JNCE - Jounce Therapeutics Inc's. (JNCE) CEO Richard Murray on Q3 2021 Results - Earnings Call Transcript

Jounce Therapeutics, Inc. (JNCE) Q3 2021 Earnings Conference Call November 4, 2021 8:00 A.M. ET Company Participants Eric Laub - Investor Relations Richard Murray - Chief Executive Officer and President Beth Trehu - Chief Medical Officer Dmitri Wiederschain - Chief Scientific Officer Kim Drapkin - Chief Financial Officer Conference Call Participants Ted Tenthoff - Piper Sandler Boris Peaker - Cowen Steven Seedhouse - Raymond James Colleen Kusy - Baird Zegbeh Jallah - Roth Capital Partners Swayampakula Ramakanth - H.C. Wainwright Presentation Operator 00:03 Good morning, ladies and gentlemen, and welcome to Jounce Therapeutics Third Quarter twenty twenty one Earnings Conference Call. At this time, all participant lines are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder this conference is being recorded at the company’s request. 00:24 I will now turn the call over to your host, Eric

For further details see:

Jounce Therapeutics, Inc's. (JNCE) CEO Richard Murray on Q3 2021 Results - Earnings Call Transcript